BIOMAT Database Logo BIOMAT Database Logo

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. 1993

M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Brown University AIDS Program, Providence, RI.

2',3'-didehydro-3'-deoxythymidine (d4T) is a pyrimidine analogue and inhibitor of reverse transcriptase with potent in vitro activity against human immunodeficiency virus (HIV). A phase I trial of d4T was conducted in 41 HIV-infected patients, 12 with AIDS and 29 with AIDS-related complex (ARC). Thirty-six patients were evaluatable. The maximum tolerated dose was 2 mg/kg/day. The dose-limiting toxicity was sensory peripheral neuropathy, which occurred in 20 patients (55%). Four patients (11%) developed hepatotoxicity. Five (14%) developed anemia requiring a transfusion but not discontinuation of drug. The mean +/- SE plasma elimination half-life at all dose levels was 1.2 +/- 0.09 h. Increased or stable absolute CD4 counts were seen in most patients. The majority of patients with detectable serum p24 antigen levels had a persistent decrease by 6 months. d4T is a promising drug for patients with AIDS or ARC. This clinical trial is continuing to determine the minimal effective dose.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000386 AIDS-Related Complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS. ARC,Lymphadenopathy Syndrome,AIDS Related Complex,Complex, AIDS-Related,Lymphadenopathy Syndromes,Syndrome, Lymphadenopathy,Syndromes, Lymphadenopathy
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Toxicokinetics of 2',3'-didehydro-3'-deoxythymidine, stavudine (D4T).
January 1999, Drug metabolism and disposition: the biological fate of chemicals,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Antiretroviral activity of stavudine (2',3'-didehydro-3'-deoxythymidine, D4T).
June 1995, Antiviral research,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Radioimmunoassay for quantitation of 2',3'-didehydro-3'-deoxythymidine (D4T) in human plasma.
June 1996, Antimicrobial agents and chemotherapy,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Nasal absorption of 2',3'-didehydro-3'-deoxythymidine (D4T) and its esters in rats.
September 1996, Biological & pharmaceutical bulletin,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Phase I/II trial of didanosine (2',3'-dideoxyinosine) in hemophiliac patients with AIDS or AIDS-related complex.
October 1993, Clinical and diagnostic virology,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Prodrugs of 2',3'-didehydro-3'-deoxythymidine (D4T): synthesis, antiviral activity, and rapid pharmacokinetic evaluation.
March 1994, Journal of pharmaceutical sciences,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial.
May 1990, The New England journal of medicine,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Prodrugs of 2',3'-didehydro-3'-deoxythymidine.
December 1993, Journal of pharmaceutical sciences,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex.
October 1995, Antimicrobial agents and chemotherapy,
M J Browne, and K H Mayer, and S B Chafee, and M N Dudley, and M R Posner, and S M Steinberg, and K K Graham, and S M Geletko, and S H Zinner, and S L Denman
2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex.
January 1990, Reviews of infectious diseases,
Copied contents to your clipboard!